Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Enterprise Value: 2020-2023

Historic Enterprise Value for Candel Therapeutics (CADL) over the last 3 years, with Dec 2023 value amounting to $42.5 million.

  • Candel Therapeutics' Enterprise Value rose 331.83% to $42.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $42.5 million, marking a year-over-year increase of 115.37%. This contributed to the annual value of $281.9 million for FY2024, which is 563.08% up from last year.
  • As of Q4 2023, Candel Therapeutics' Enterprise Value stood at $42.5 million, which was up 359.32% from -$16.4 million recorded in Q3 2023.
  • Candel Therapeutics' Enterprise Value's 5-year high stood at $222.6 million during Q3 2021, with a 5-year trough of -$35.1 million in Q4 2020.
  • For the 3-year period, Candel Therapeutics' Enterprise Value averaged around $34.9 million, with its median value being $6.2 million (2022).
  • In the last 5 years, Candel Therapeutics' Enterprise Value skyrocketed by 504.28% in 2021 and then plummeted by 350.02% in 2023.
  • Quarterly analysis of 4 years shows Candel Therapeutics' Enterprise Value stood at -$35.1 million in 2020, then soared by 504.28% to $141.7 million in 2021, then crashed by 112.94% to -$18.3 million in 2022, then soared by 331.83% to $42.5 million in 2023.
  • Its last three reported values are $42.5 million in Q4 2023, -$16.4 million for Q3 2023, and -$15.5 million during Q2 2023.